Ledger.Open graph →
SEC Form D · filed December 15, 2023

KAZIA THERAPEUTICS LTD

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SYDNEY NSW, Channel Islands
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

John Friend · New York, NYExec · DirectorBryce Carmine · SYNDEY NSW, Channel IslandsDirectorEbru Davidson · SYNDEY NSW, Channel IslandsDirectorSteven Coffey · SYNDEY NSW, Channel IslandsDirectorKaren Krumeich · Baltimore, MDExecJohn Friend · Tucson, AZExec · DirectorBryce Carmine · SYNDEY NSW, Channel IslandsDirectorKaren Krumeich · SYNDEY NSW, Channel IslandsExecEbru Davidson · SYNDEY NSW, Channel IslandsDirectorSteven Coffey · Austin, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗